Replies to post #329710 on Anavex Life Sciences Corp (AVXL)

[Investor2014]

I de-risk across my biotech portfolio whenever it seems appropriate. Probably not any further with $AVXL at this time given my negative cost basis.

Who knows into 2022 it could become appropriate again.